State will subsidize 15% of obesity medications for monitored patients

The government will subsidize 15% of obesity medications for patients under a specific hospital care plan. This initiative requires patients to be monitored by a multidisciplinary obesity team and to follow a comprehensive treatment approach. The new decree aims to ensure equitable access to these medications within the National Health Service. Eligible medications must be prescribed by specialists in endocrinology, internal medicine, or pediatrics, as part of an integrated care pathway established last year.